Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an update.
Wai Chun Bio-Technology Ltd. has released a supplemental announcement regarding its 2024 Annual Report, specifically addressing the Share Option Scheme. The announcement highlights that no share options were granted, exercised, or cancelled during the year ending June 2024, with a significant number of options lapsing. This development may impact the company’s financial strategy and stakeholder engagement, as the share option scheme remains in force for ten years from its adoption date.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and providing biotechnology products and services, with a market presence indicated by its listing on the Hong Kong Stock Exchange.
Average Trading Volume: 416,154
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.63M
For a thorough assessment of 0660 stock, go to TipRanks’ Stock Analysis page.